Company: TVRD
Filing Date: 2025-02-14
Form Type: S-4/A
Source: 0001104659-25-013053
Chunk: 793

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: S-4/A
Chunk 793
---
------:|:--|:-----|:--|:-------------------------------|:--|------:|:--|:-----|:--|:--|:--|------:|:--|:--|
| Operating cash outflows relating to operating leases                    | ​    | ​ | ​                               | $ | 4,363 | ​ | ​    | ​ | ​ | $ |   500 | ​ | ​    | ​ | ​                              | $ | 4,363 | ​ | ​    | ​ | ​ | $ | 1,489 | ​ | ​ |
| ROU assets obtained in exchange for new operating lease liabilities     | ​    | ​ | ​                               | $ |     — | ​ | ​    | ​ | ​ | $ | 6,779 | ​ | ​    | ​ | ​                              | $ |     — | ​ | ​    | ​ | ​ | $ | 6,779 | ​ | ​ |
| Remaining lease term – operating leases (years)                         | ​    | ​ | ​                               | ​ |   0.1 | ​ | ​    | ​ | ​ | ​ |  10.4 | ​ | ​    | ​ | ​                              | ​ |   0.1 | ​ | ​    | ​ | ​ | ​ |  10.4 | ​ | ​ |
| Discount rate – operating leases                                        | ​    | ​ | ​                               | ​ |    —% | ​ | ​    | ​ | ​ | ​ | 12.4% | ​ | ​    | ​ | ​                              | ​ |    —% | ​ | ​    | ​ | ​ | ​ | 12.4% | ​ | ​ |

There are no other future minimum cash lease payments under the Assignment Agreements as of September 30, 2024. Future non-cash lease payments under the Assignment Agreements are $3,417, which are included within operating lease liability — current as of September 30, 2024. This non-cash lease payment is due at the end of the modified lease term, which is November 1, 2024. 18. Related Party Transactions As of September 30, 2024, Vifor International owned 616,397, or 13.5%, of the Company’s common stock. CSL Vifor and its affiliates are considered related parties as of September